Literature DB >> 30287

Withdrawal syndromes associated with antipsychotic drugs.

G Gardos, J O Cole, D Tarsy.   

Abstract

Withdrawal symptoms frequently follow abrupt discontinuation of antipsychotic compounds. In addition to other somatic symptoms, withdrawal-emergent dyskinesias may be observed. "Covert dyskinesia" refers to a masked form of tardive dyskinesia that becomes clinically detectable only after antipsychotic drugs are withdrawn or their dosage is reduced. Withdrawal dyskinesia appears under similar circumstances but disappears spontaneously in 6 to 12 weeks. Cholinergic overactivity and changes in dopamine-acetylcholine balance in the basal ganglia may underlie these withdrawal syndromes. The principal value of the concept of covert dyskinesia is in the secondary and tertiary prevention of tardive dyskinesia through early discovery and treatment.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 30287     DOI: 10.1176/ajp.135.11.1321

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  21 in total

1.  The management of neuroleptic-induced CNS effects.

Authors:  B F Hoffman; M V Seeman
Journal:  Can Fam Physician       Date:  1981-10       Impact factor: 3.275

2.  Abnormal involuntary movements: side-effect of neuroleptic drugs.

Authors:  L K Oyewumi
Journal:  Can Fam Physician       Date:  1982-01       Impact factor: 3.275

3.  Covert Dyskinesia With Aripiprazole: A Case Report.

Authors:  Yassir Mahgoub; Ahmad Hameed; Andrew Francis
Journal:  Prim Care Companion CNS Disord       Date:  2016-06-09

4.  Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats.

Authors:  R E See; G Ellison
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 5.  Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

Authors:  Irma Convertino; Alice Capogrosso Sansone; Alessandra Marino; Maria T Galiulo; Stefania Mantarro; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

6.  Acute amitriptyline withdrawal and hyponatraemia. A case report.

Authors:  P Davison; J Wardrope
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606

Review 7.  Drug withdrawal syndromes-- a literature review.

Authors:  G C Hodding; M Jann; I P Ackerman
Journal:  West J Med       Date:  1980-11

Review 8.  Management of tardive dyskinesia: current update.

Authors:  G M Simpson; E H Pi; J J Sramek
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

Review 9.  Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly.

Authors:  Carlos Estevez-Fraga; Paul Zeun; Jose Luis López-Sendón Moreno
Journal:  Drugs Aging       Date:  2018-11       Impact factor: 3.923

Review 10.  A clinical guide to antipsychotic drugs.

Authors:  J T Schwartz; A W Brotman
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.